Drug Trial Radar · NCT05536011
WAKIX® (Pitolisant) Pregnancy Registry
Last checked: Nov 20, 2026Latest source record: Jun 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
1,329
Planned (sponsor's estimate)
Start
Aug 24, 2021
Primary completion
Jun 30, 2030
Study completion Jun 30, 2030
Sponsor
- Lead sponsor
- Harmony Biosciences Management, Inc.Industry
- Sponsor type
- Industry
- First posted
- Sep 10, 2022
Design
- Study type
- Observational
- FDA-regulated drug
- Yes
- Who can join
- Female only
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The WAKIX (pitolisant) Pregnancy Registry is a US-based, prospective, observational cohort study designed to evaluate the association between pitolisant exposure during pregnancy and subsequent maternal, fetal, and infant outcomes.
Conditions
- Pregnancy Related
- Narcolepsy
Interventions
PitolisantDrug
Exposure to at least one dose of pitolisant at any time during pregnancy
Comparator ProductsDrug
Exposure to at least one dose of a comparator product at any time during pregnancy
Primary outcomes
What the sponsor says the trial is designed to measure.
- Major congenital malformationTime frame: Enrollment through the infant's first year of life
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Evidera (PPD)
Morrisville, North Carolina · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.